Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 47Breast Neoplasms 34Breast Neoplasms, Male 3Neoplasms 2Neoplasm Metastasis 2Infertility 2Advanced Breast Cancer 2Sexual Dysfunction, Physiological 1Recurrence 1Prostate Adenocarcinoma 1Primary Ovarian Insufficiency 1Osteoporosis 1Osteitis Deformans 1Leiomyoma 1Hot Flashes 1Hemorrhage 1Breast Cancer Invasive 1Anemia 1Advanced Prostate Cancer 1Advanced Metastatic Breast Cancer 1

Interventions

Letrozole 4Clomiphene 3follitropin alfa 2Metformin 2Goserelin 2Cyclophosphamide 2follitropin beta 1cetrorelix 1Urofollitropin 1Triptorelin Pamoate 1Thioctic Acid 1Therapeutics 1Tamoxifen 1Surgical Procedures, Operative 1Sperm Injections, Intracytoplasmic 1Neoadjuvant Therapy 1Congresses as Topic 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Infertility × Goserelin × Clear all
NCT00068601 2019-12-30

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
257 enrolled 8 charts
Breast

Breast Neoplasms, Infertility

NCT00427245 2013-08-07

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Breast

Breast Neoplasms, Infertility

Data powered by HemOnc (CC BY 4.0) Colophon âš¡